Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male and female subjects with Onchocerca volvulus infection~Exclusion Criteria:~* Pregnant or breast feeding women; coincidental loiasis

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Moxidectin (Type: EXPERIMENTAL): Moxidectin 8mg
- Ivermectin (Type: ACTIVE_COMPARATOR): Ivermectin 150 mcg/kg

Based on this trial design, predict the completion outcome and termination type (if applicable).